Objectives: It is difficult to draw conclusions about the prudence of antibiotic use in different hospitals by directly comparing usage figures. We present a patient case-mix adjustment model of antibiotic use to rank hospitals while taking patient characteristics into account.
Introduction
Direct comparison of antibiotic consumption between hospitals in order to judge antimicrobial policy or appropriate use is difficult. Such comparisons are tempting, however, to obtain a rapid overview of the situation. Moreover, policymakers may want to use data without understanding its limitations. Antibiotic consumption in a hospital depends on the prescription policy, but also on the patients' characteristics, i.e. case-mix and treatments provided.
Only a few reports have focused on risk-adjusted models of variability of antibiotic use. 1 -6 Case-mix adjustment is a method of benchmarking and comparing differences between hospitals by adjusting the figures not just according to the type of hospital, but also according to the type of patient. Previously, we presented the case-mix-adjusted prevalence of healthcare-associated infection (HAI) in 30 Finnish adult acute care hospitals that took part in the prevalence survey, and compared the adjusted and observed ranks. 7 More than one-third of hospitals had a better observed position in ranking than predicted by the adjusted figures. The study presented here investigated how the ranking order of antibiotic use in different Finnish acute care hospitals changed compared with the observed rankings when the data on antibiotic use were adjusted according to various patient case-mix variables. patients; 703 with and 7531 without HAI. Of these patients, 3224 (39%) received at least one antibiotic, 1136 (14%) received at least two and 268 (3%) received at least three antibiotics during the study day. 8 In addition, 3805 (46%) patients, who were present during the study day, had received at least one antibiotic during the study day or the previous 6 days. The use of antibiotics in Anatomical Therapeutic Chemical (ATC) classes J01 and P01 was measured using the ratio of antibiotic use-days/100 patient-days (use density) during a 7 day period (the study day and the previous 6 days), as described previously. 8 Briefly, for the use density, the first five antimicrobials on patient charts were recorded and each antibiotic given on any day within the week contributed to the total number of use-days, with the patient maximum being 35 use-days. If the drug had been used at any time during the day, the whole day was considered a use-day. Patient-days in the denominator were calculated by subtracting the date of admission from the date of the study day and then adding one. Had the patient been hospitalized for more than 1 week, only 7 days were counted.
Patients and methods
Case-mix-adjusted use-days/100 patient-days for all hospitals were calculated as described by Kritsotakis et al. 9 and Kanerva et al. 7 using multivariable negative binomial regression and logistic regression models as well as an indirect standardization method. First, we calculated the expected probabilities of antibiotic use density for each patient according to the patient's individual risk factors, using the multivariable negative binomial regression model. For the logistic regression model, the response variable was whether the patient received at least two antibiotics during the study day. In the models, we included variables that were either previously known reasons for antibiotic use (i.e. infection) or risk factors for infection: age; sex; severity of underlying diseases as measured by the Charlson index and the McCabe classification; intensive care; haematology; preceding surgery; respirator; central venous and urinary catheters; community-associated infection; pneumonia and bacteraemia as HAIs; other types of HAI; and contact isolation due to methicillin-resistant Staphylococcus aureus (MRSA). Second, the expected probabilities of each patient were aggregated by hospital to determine the mean predicted antibiotic use in each hospital. The standardized ratio was calculated by dividing the observed prevalence by the mean predicted risk in each hospital. Third, we determined adjusted use densities by multiplying standardized ratios by the observed use density in the entire study population.
In the regression analyses, the multiple imputation method served to replace missing values in the covariates. We used robust standard errors to take hospital clustering into account. For the multivariable use density model, we used negative binomial regression to offset overdispersion in the Poisson regression model.
We performed statistical analyses with SPSS software (version 18.0, Chicago, IL, USA).
Results
Of the parameters included in the model, age, sex, severity of underlying disease, community-onset infection or HAI as well as being in contact isolation due to MRSA remained significant predictors of antibiotic use ( Table 1) . The mean observed antibiotic use density was 62 use-days/100 patient-days (range by hospital, 46-99), and the case-mix-adjusted use density varied between 49 and 114 use-days/100 patient-days ( Table 2 ). The case-mix adjustment ranked the hospitals differently: the ranking order changed one position in 12 (40%) hospitals and more than two positions in 13 (43%) hospitals when the case-mix adjusted figures were compared with those observed. In 24 hospitals (80%) the observed antibiotic use density was lower and in 14 (57%) the use-density ranking position was lower than that predicted by the case-mix-adjusted use density or ranking order, respectively.
A mean 15% of patients in all hospitals (range by hospital, 7%-36%) received more than one antibiotic during the study day. If the hospitals were ranked according to the percentage of patients receiving more than one antibiotic, 19 (63%) of the hospitals had a smaller proportion of patients receiving more than one antibiotic than the proportion predicted by the adjusted prevalence on the study day.
Discussion
The ranking of the hospitals according to the patient case-mix adjustment of antibiotic use differed from the ranking according to observed use. To explore differences in antibiotic use or possibilities for improvement, adjustment according to these factors is essential.
In addition to variation in antibiotic-describing policies and different methods in measuring use, patient characteristics and hospital activities also influence antibiotic use. The presence of community-acquired infection and risk factors for HAI, including the severity and type of both acute and underlying diseases, treatments, procedures and indwelling devices, and the organization of healthcare (early discharge to a step-down unit) all affect the probability of receiving antibiotics. In our model, infections-especially severe HAI-were the strongest predictors of Kanerva et al.
antibiotic use. This finding is in line with that of a French study in which a high prevalence of healthcare-associated urinary tract infection and pneumonia explained 26% of the variability in antibiotic use. 1 Risk factors for antibiotic use can also be defined at the hospital level according to the distribution and presence of different medical specialties (haematology, infectious diseases, trauma and amount of clean contaminated surgery using antimicrobial prophylaxis) and the level of care (primary, secondary and tertiary), or less well according to the size of the hospital. In addition to the number of antibiotics used, the antibiotic prescription policy also affects the spectrum and selection of antibiotics.
We measured antibiotic use according to use density for practical reasons. Although collecting data on use-days within the previous week was feasible in the prevalence survey, we did not collect data on doses. This method also avoids the shortcomings of the defined daily dose (DDD) methodology, including differences between DDD and doses generally used in certain indications and patient groups (e.g. those with renal insufficiency, or those who are very light, overweight or young). However, our method may overestimate use, as we interpreted even a single given dose as a use-day. To offset this, we also included the total patient-days in the denominator, regardless of the actual hours spent on the ward. Neither use-days nor DDD take the antibiotic spectrum into account; the use of two narrow-spectrum antibiotics yields twice the number of use-days as compared with broad-spectrum antibiotics. In addition to emergency care guidelines and 'current care' evidence-based treatment guidelines covering mainly community-acquired infection, there are no national guidelines on antibiotic use in Finland. We did not collect data on whether hospitals had their own or regional guidelines on antibiotic use.
The data were based on a prevalence survey, which is another limitation in the study: there is always chance and e.g. seasonal variation in these figures. However, the data covered a very large proportion of the Finnish acute care hospitals.
The model we used in this study was similar to what we used previously to benchmark HAI prevalences in these hospitals. 7 Other models, such as the zero-inflated Poisson regression model and the zero-inflated negative binomial model, might be more suitable for modelling antibiotic use-days and worth testing in the future. 
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The variables we used in the model were all related to patient characteristics. MacDougall and Polk 5 used parameters at the hospital level, including teaching status, number of beds, intensive care unit days, surgical volume, and all cases of pneumonia, urinary tract infection and bacteraemia, in their study of 130 US hospitals, as did Amadeo et al. 1 The economical case-mix index, calculated using diagnosis-related groups, correlated with antibiotic use in acute care hospitals in a Swiss study and in nursing homes in New York. 4, 6 The best set of easily and widely available parameters that would describe both patients and hospital activities in terms of antibiotic use remains to be determined. Case-mix adjustment may be a useful tool for benchmarking hospital antibiotic use.
